Altimmune, Inc. (ALT) Tops Q1 EPS by 12c

Altimmune, Inc. (NASDAQ: ALT) reported Q1 EPS of ($0.26), $0.12 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $5 thousand.

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
• Bain Capital Exited Flash Memory Maker Kioxia, Executive Says - Bloomberg
• ISS and Glass Lewis back Aterian asset sale ahead of shareholder vote